As clinical evidence of circulating GPC-4 in PD is missing so far, we therefore investigated circulating GPC-4 as a potential biomarker by measuring its levels in different biofluids of PD patients with well-characterized clinical profiles. Here, GPC4 is linked to Parkinson disease.